Covaxin trial on children likely to begin at Delhi AIIMS from Tuesday
New Delhi: The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India's first indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin.…
Read More...
Read More...